Page last updated: 2024-10-27

fluconazole and Adnexitis

fluconazole has been researched along with Adnexitis in 3 studies

Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.

Adnexitis: Inflammation of the uterine appendages (ADNEXA UTERI) including infection of the FALLOPIAN TUBES (SALPINGITIS), the ovaries (OOPHORITIS), or the supporting ligaments (PARAMETRITIS).

Research Excerpts

ExcerptRelevanceReference
"One hundred and sixty five women with diagnosis of pelvic inflammatory disease were randomized into three equal groups getting ciprofloxacin (500 mg) and tinidazole (600 mg) combination twice daily for 7 days (Group 1), a kit containing fluconazole (150 mg), azithromycin (1 gm) and secnidazole (2 mg) as one time dose (Group 2) and Doxycycline 100mg twice daily and metronidazole 200 mg thrice daily for seven days (Group 3)."9.10Ciprofloxacin-tinidazole combination, fluconazole- azithromicin-secnidazole-kit and doxycycline- metronidazole combination therapy in syndromic management of pelvic inflammatory disease: a prospective randomized controlled trial. ( Arora, R; Batra, S; Malhotra, M; Sharma, JB; Sharma, S, 2003)
"One hundred and sixty five women with diagnosis of pelvic inflammatory disease were randomized into three equal groups getting ciprofloxacin (500 mg) and tinidazole (600 mg) combination twice daily for 7 days (Group 1), a kit containing fluconazole (150 mg), azithromycin (1 gm) and secnidazole (2 mg) as one time dose (Group 2) and Doxycycline 100mg twice daily and metronidazole 200 mg thrice daily for seven days (Group 3)."5.10Ciprofloxacin-tinidazole combination, fluconazole- azithromicin-secnidazole-kit and doxycycline- metronidazole combination therapy in syndromic management of pelvic inflammatory disease: a prospective randomized controlled trial. ( Arora, R; Batra, S; Malhotra, M; Sharma, JB; Sharma, S, 2003)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ressel, GW1
Malhotra, M1
Sharma, JB1
Batra, S1
Arora, R1
Sharma, S1
Sing, Y1
Ramdial, PK1
Ibrahim, T1

Trials

1 trial available for fluconazole and Adnexitis

ArticleYear
Ciprofloxacin-tinidazole combination, fluconazole- azithromicin-secnidazole-kit and doxycycline- metronidazole combination therapy in syndromic management of pelvic inflammatory disease: a prospective randomized controlled trial.
    Indian journal of medical sciences, 2003, Volume: 57, Issue:12

    Topics: Adolescent; Adult; Azithromycin; Ciprofloxacin; Doxycycline; Drug Therapy, Combination; Female; Fluc

2003

Other Studies

2 other studies available for fluconazole and Adnexitis

ArticleYear
CDC releases 2002 guidelines for treating STDs: Part I. Diseases characterized by vaginal discharge and PID.
    American family physician, 2002, Nov-01, Volume: 66, Issue:9

    Topics: Anti-Infective Agents; Candidiasis, Vulvovaginal; Female; Fluconazole; Humans; Metronidazole; Pelvic

2002
Cryptococcosis masquerading as a tuboovarian abscess.
    International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists, 2008, Volume: 27, Issue:1

    Topics: Abscess; Adult; Antifungal Agents; Cryptococcosis; Cystadenocarcinoma, Mucinous; Diagnosis, Differen

2008